Tower Research Capital LLC (TRC) - NOVUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NOVUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$21,000
+2000.0%
22,618
+7593.2%
0.00%–
Q1 2018$1,000
-83.3%
294
-80.6%
0.00%
-100.0%
Q4 2017$6,000
-79.3%
1,515
-73.0%
0.00%
-50.0%
Q3 2017$29,000
+480.0%
5,606
+606.9%
0.00%
+100.0%
Q2 2017$5,000–793–0.00%–
 Download
Other shareholders
NOVUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 80,069$1,233,0000.56%
View complete list of NOVUS THERAPEUTICS INC shareholders